GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
122 hedge funds and large institutions have $581M invested in G1 Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 43 increasing their positions, 35 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 125 → 122 (-3)
17% less call options, than puts
Call options by funds: $10.9M | Put options by funds: $13.1M
Holders
122
Holding in Top 10
1
Calls
$10.9M
Puts
$13.1M
Top Buyers
| 1 | +$14.5M | |
| 2 | +$14.5M | |
| 3 | +$13.3M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$9.43M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.31M |
Top Sellers
| 1 | -$22.3M | |
| 2 | -$15.8M | |
| 3 | -$11.9M | |
| 4 |
Goldman Sachs
New York
|
-$8.85M |
| 5 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$8.54M |